Edition:
United States

Search Results  for '600276.SS'

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Jiangsu Hengrui Medicine Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

29 Oct 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Jiangsu Hengrui Medicine Co Ltd (600276-SH)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

01 Nov 2016 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Jiangsu Hengrui Medicine Co., Ltd.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

07 Oct 2016 Wright Reports 65 $75.00

Jiangsu Hengrui Medicine Co., Ltd. (600276) - Financial and Strategic SWOT Analysis Review

Jiangsu Hengrui Medicine Co., Ltd. (600276) - Financial and Strategic SWOT Analysis Review Summary Jiangsu Hengrui Medicine C...

04 Oct 2016 GlobalData 48 $300.00

Jiangsu Hengrui Medicine Co., Ltd. (600276) - Financial and Strategic SWOT Analysis Review

Jiangsu Hengrui Medicine Co., Ltd. (600276) - Financial and Strategic SWOT Analysis Review Summary Jiangsu Hengrui Medicine C...

19 Sep 2016 GlobalData 48 $300.00

Is There Long-Term Value in Jiangsu Hengrui Medicine Co., Ltd?

15 Aug 2016 Sadif Analytics Prime 12 $25.00

Jiangsu Hengrui Medicine Co., Ltd. (600276) - Financial and Strategic SWOT Analysis Review

Jiangsu Hengrui Medicine Co., Ltd. (600276) - Financial and Strategic SWOT Analysis Review Summary Jiangsu Hengrui Medicine C...

03 Jun 2016 GlobalData 47 $300.00

Will Jiangsu Hengrui Medicine Co., Ltd Deliver Long-Term Returns?

16 May 2016 Sadif Analytics Prime 12 $25.00

Thomson Reuters Stock Report - Jiangsu Hengrui Medicine Co Ltd (600276-SH)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

10 May 2016 Thomson Reuters Stock Report 11 $25.00

京 華 山 一 [恒瑞醫藥(600276 CH):業績增長強勁,創新藥步入收穫期](15/04/2016)

最新發展 恒瑞醫藥公佈15年業績全年營業收入同比增長25.0%至93.2億元,淨利潤同比增長43.3%至21.7億元。 催化劑 业绩稳定增长,毛利率大幅提升。公司15年毛利率增加2.9个百分点至85 %,核心利润率增长3.2个百分点至26...

15 Apr 2016 Core Pacific - Yamaichi International (H.K.) Limited 4 $23.00